Catalyst Wire Dossier Catalyst Wire Dossier

Human menstrual blood-derived mesenchymal stem cells

· S-Evans Biosciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Human menstrual blood-derived mesenchymal stem cells, covering 2012-06-07 to 2012-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis [Phase 1, Phase 2]

See pricing